CXCL5 and cholangiocarcinoma: The CXCL5/CXCR2 axis promotes lymphangiogenesis, epithelial–mesenchymal transition (EMT), and matrix metalloproteinase (MMP) upregulation in cholangiocarcinoma (CCA) [21].